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doi:10.1016/j.ejvs.2011.03.013Abstract Objectives: Duplex ultrasound has become the reference standard in assessing the
morphology and haemodynamics of the lower limb veins. The project described in this article
was an initiative of the Union Internationale de Phle´bologie (UIP). The aim was to obtain
a consensus of international experts on the methodology and terminology to be used for assess-
ment after treatment of incompetent superficial and perforating veins in the lower limb by
ultrasound imaging.
Design: The study design was consensus meetings leading to a consensus document.
Methods: The UIP invited group submitted relevant literature references and written contribu-
tions concerning the methodology, terminology and value of duplex imaging after treatment.
The authors prepared a draft document that was circulated to a larger group of experts and
revised according to the comments received. Eventually, all participants agreed upon the final
version of the article.education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’
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90 M. De Maeseneer et al.Results: Formal analysis of the results of interventions for varicose veins relies on adequate
preoperative assessment and a careful description of the procedure employed. The timing
of investigations of outcome should be classified as immediate (1e4 weeks), short-term
(1 year), midterm (2e3 years) and long-term (5 years or more). The examination should employ
standard methodology and formally described variables, which can be tailored to the interven-
tion that was undertaken. The experts have made detailed recommendations concerning the
methods to be used for duplex ultrasound examination and reporting after various treatments
for varicose veins, including novel treatments under scientific study.
Conclusions: Duplex ultrasonography is a fundamental component of the investigation of the
lower limb venous system after treatment for varicose veins.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Duplex ultrasound (DUS) is the most frequently used
investigation to evaluate the outcome of treatments for
chronic venous disease (CVD). Endovenous ablation (EVA) of
a vein using laser or radiofrequency energy, or ultrasound-
guided injection of sclerosant foam may all be evaluated
using this technique. DUS imaging is the ideal non-invasive
method for follow-up, as it provides anatomical and hae-
modynamic information about the treated veins.1e9 DUS
can detect the early stages of recurrent varicose veins,
before they become apparent clinically.10 Serial DUS
imaging can not only help to understand the clinical
evolution of the individual patient after treatment for CVD,
but also has the potential to increase the general knowl-
edge of events leading to clinical recurrence. Thus, long-
term follow-up using DUS extends the understanding of
the natural evolution of varicose vein disease.
Widely different DUS criteria have been used to assess
the outcome of treatment for venous disease; often, there
is very little information about the preoperative morpho-
logical and haemodynamic condition of veins. Currently,
there is no systematic agreement from phlebology or
vascular societies on how DUS imaging is best performed, or
interpreted for follow-up. Standardisation of follow-up
imaging and reporting would reduce the confusion and
give better clarity to the end points of treatment.11e13 The
aim of this document is to summarise best practice for
venous DUS examination of the legs after treatment,
derived partly from the (limited) published evidence, and
also agreed upon by an expert group that regularly uses this
technology.Methodology
The Union Internationale de Phle´bologie (UIP) invited
a group of international experts in the field of DUS inves-
tigation with MDM as the Chair. They were invited to submit
relevant literature references and written contributions
concerning the methodology and value of DUS imaging after
treatment. Personal expert opinions were sought, which did
not necessarily reflect policies of scientific or medical
societies to which the individuals were affiliated. This
process was not intended to form a systematic review of
the literature, but to provide evidential support to the
consensus recommendations made in the final document.
Consensus meetings began with interested experts at
the Venous Forum of the Royal Society of Medicine in
Manchester, November 2007, and subsequent meetingswere held with smaller subgroups looking at specific areas.
The aim was to define a systematic method of DUS imaging
and reporting, which was simple to use and could be
employed to audit the outcome of various treatments for
varicose veins, including novel treatments under scientific
study. The authors acknowledge that many of the state-
ments only reflect the opinion of the consensus group
rather than being supported by published scientific
evidence. This reflects the fact that existing publications
have used widely varying criteria for both methods and
interpretation of DUS imaging after treatment.
Only the specifics of DUS imaging for the evaluation of
treatment are considered. However, it is critical that these
go together with the essentials of good clinical and patient-
focussed evaluation. The tools for these have been pub-
lished previously, such as Clinical, etiologic, anatomic and
pathophysiologic data (CEAP), Venous Clinical Severity
Score (VCSS) and other generic and condition-specific (e.g.,
the Aberdeen Varicose Vein Symptom Severity score,
AVVSS) quality of life (QoL) assessments.14e19 The rela-
tionship of these tools to specific DUS appearances is
unfortunately not yet established. Further work is required,
which should be stimulated by this consensus document. It
is anticipated that, in future studies of global outcome
following different treatment strategies, the present
document should not be used in isolation, but should be
used in conjunction with similar existing or newly produced
consensus documents on clinical reporting.
While this consensus deals primarily with the DUS eval-
uation after treatment, it cannot ignore the state of the
pre-treatment evaluation. Anatomical and haemodynamic
characteristics of superficial venous insufficiency often vary
widely between patients. Therefore, clear recording
of pre-treatment clinical features and DUS findings is
essential, as they may influence the interpretation of post-
treatment results and expectations. The detailed docu-
mentation of the type of treatment employed is also
important for the understanding of subsequent DUS find-
ings. For instance, the length of the incompetent segment
of the great saphenous vein (GSV) that was treated should
be recorded, and the anterior accessory saphenous vein
(AASV) should be distinguished clearly from the GSV. These
pre-treatment details are unfortunately not always avail-
able, which may significantly reduce the value of DUS-
based follow-up. The previous consensus document on
recurrent veins after surgery (at that time called ‘REVAS’),
which integrated clinical and DUS findings, reported that,
for the majority of patients, little information was
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the date it was done.20,21 In the recently published Vein-
TERM consensus document, the acronym PREVAIT (PREs-
ence of Varices (residual or recurrent) After InTervention)
has been introduced, referring to clinical scenarios where
varices cannot definitely be classified as recurrent or
residual.22 In case of PREVAIT, interpretation of DUS find-
ings is always difficult and potentially ambiguous. The
present consensus document seeks to address this by
insisting on the recording of all useful prior information,
and on the requirement for prospective DUS evaluation for
adequate interpretation.DUS Imaging before Treatment
The basic principles of venous DUS investigation for vari-
cose veins have been described in a previous UIP Consensus
Document, and these remain applicable.8 The ultrasound
anatomy of the superficial and perforating veins has also
been described in a UIP Consensus Document.9 Since these
publications, new treatments have emerged for which
additional descriptive features are required, and these are
included in the present document.
The minimum requirements for pre-treatment DUS
assessment are described in Table 1. Other features may be
recorded, but should not be at the expense of the minimum
data set.
To assess the involvement of any pathology of the deep
venous system, scanning the deep veins and looking for
patency and the presence/absence of reflux is an important
part of the evaluation of a patient before treatment of
varicose veins. Some patients present with superficial vein
disease due to underlying primary deep venous incompe-
tence or secondary (post-thrombotic) obstruction and/or
reflux. This will obviously influence the long-term outcome
of treatment of superficial or perforating vein incompe-
tence adversely and should therefore be included in the
initial assessment as well as in further follow-up. InTable 1 Preoperative duplex imaging.
1. Deep veins: assessment for patency and reflux
- common femoral vein (CFV)
- popliteal vein
2. Junctions: assessment for reflux (terminal valve/
pre-terminal valve)
- saphenofemoral junction (SFJ)
- saphenopopliteal junction (SPJ)
3. Main trunks: diameter measurement and assessment
of reflux (in the saphenous compartment):
- great saphenous vein (GSV)
- anterior accessory saphenous vein (AASV)
- posterior accessory saphenous vein (PASV)
- small saphenous vein (SSV)
- thigh extension of SSV/Giacomini vein
4. Tributaries: if incompetent
5. Non-saphenous veins: if incompetent
6. Perforating veins: diameter measurement and
assessment of refluxpatients with a previous history of deep vein thrombosis,
the deep venous system should be examined in both the
lying and standing position to check for residual obstruction
and reflux, respectively, as described previously.8
When assessing superficial veins, patients should be
examined in the standing position where possible, to stan-
dardise measurements of venous diameter and reflux. If
obesity or other cardio-respiratory conditions make this
impractical, it is vital that any follow-up imaging is done in
the same position.
Diameter measurement
This should be performed in transverse view and the outer
diameter should be measured (including the vein wall) to
compare this with the postoperative diameter after endo-
venous ablation. For the GSV trunk, diameter measurements
of the incompetent segment should be made 3 cm below the
saphenofemoral junction (SFJ), at mid-thigh level, at the
knee and also at mid-calf level. The saphenous trunk should
bemeasured at a site where there is no focal (or aneurysmal)
dilation of the trunk.23 Similarly, the AASV should be
measured 3 cm below the SFJ and at mid-thigh (if the trunk
exists at this level). For the small saphenous vein (SSV), the
trunk should be measured 3 cm below the saphenopopliteal
junction (SPJ) where the pre-terminal valve, if present, is
located. A mid-calf measurement should also be made.
Assessment of reflux
The presence of flow in any part of the arterial or venous
system assumes the existence of a pressure gradient; nor
can venous reflux exist without a pressure gradient. In an
individual standing still and breathing normally, flow in
both competent and incompetent veins is very slow but
remains antegrade. To detect the presence of reflux, it is
necessary to create a pressure gradient in the venous
system. This is usually achieved either by a Valsalva
manoeuvre, which creates high pressure in the venous
system, or by compressionerelease (calf squeeze), which
creates a low pressure in the venous system during release.
There is a lack of standardisation in reflux assessment;
the duration of reflux in seconds (reflux time) is used most
commonly. Reflux is usually defined as retrograde flow
lasting for more than 0.5 s, whereas less than 0.5 s is
defined as normal or no reflux.8 However, the reflux time
can only be used to distinguish between a competent and
incompetent vein segment and is therefore a qualitative
evaluation. Peak reflux velocity (m s1) and the rate of
reflux (ml min1) may be used to provide a quantitative
evaluation of reflux.24 Manual limb compression by calf
squeeze cannot be standardised; hence, is not ideal for
quantitative measurement of reflux. To obtain more
reproducible results, two standardised methods for testing
reflux have been evaluated in healthy subjects and patients
with venous disease:
1. Standardised Valsalva manoeuvre: This consists of
forced exhalation into a special tube system that
measures expiratory pressure (JeannereteValsalva
device, Eisenhut e VET Ag, Allschwil, Switzerland).
Table 2 Details of treatment.
1. Treatment of junction (SFJ, SPJ)
- none
- flush SFJ ligation
- lower ligation with preservation of the junction itself
- repeat ligation of SFJ or alternative procedure for
recurrence
- adjunctive procedures: closing opening in cribriform
fascia, prosthetic patch on SFJ/SPJ
2. Treatment of main trunk (GSV, AASV, SSV)
- none
- endovenous laser ablation
- radiofrequency ablation
- (ultrasound-guided) foam/liquid sclerotherapy
- stripping with vein stripper (invaginated or not)
or cryostripping
- length/site of treated trunk(s)
3. Treatment of tributaries
- none
- phlebectomies
- foam/liquid sclerotherapy
- endovenous laser treatment
- delayed phlebectomies or sclerotherapy
4. Treatment of perforating veins
- none
- phlebectomy and epifascial ligation
- foam/liquid sclerotherapy
- radiofrequency ablation
- endovenous laser ablation
- subfascial ligation (SEPS)
- site of treated perforating vein(s)
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0.5 s and held for at least 3 s, to avoid false positive
prolonged reflux due to a lack of transvalvular pressure
gradient. This standardised Valsalva manoeuvre is
highly reproducible in the proximal leg veins with
coefficients of variation ranging from 10.4% to 13% for
reflux time and from 11.5% to 16.4% for peak reflux
velocity.25 The Valsalva manoeuvre, however, cannot
be used to assess reflux in veins distal to competent
valves.
2. Standardised cuff inflationedeflation method: An
automatic or manual pedal cuff inflator produces rapid
inflation and deflation of cuffs placed at different
levels on the leg.26
In most countries, these standardised methods are not
used routinely. Most assessors use a Valsalva manoeuvre,
together with calf compressionerelease to characterise
venous incompetence. At the level of the SFJ, the combi-
nation of these two manoeuvres is essential to assess the
state of the terminal valve (TV) of the GSV. The TV and the
pre-terminal valve (PTV) of the GSV should both be identi-
fied, to distinguish between incompetence of both valves or
only one of the two.9 The assessment of TV and PTV hae-
modynamics is best achieved through the combined use of
colour flow and Doppler modalities, with the sample volume
placed above each valve to test for the presence or absence
of reflux (at common femoral vein level to test the TV and at
the most proximal part of the GSV to test the PTV).
In the groin, the lymph node area should be studied,
particularly in patients with recurrent varicose veins. Reflux
in a lymph node vein network (LNVN) should be sought,
tracing it upwards looking for a connection with the common
femoral vein or pelvic veins, and downwards looking for
a connection with GSV, AASV or other varicose veins.27
In multiparous women, a leash of tortuous veins may also
be seen within the saphenous compartment or superficial to
the SFJ in the thigh. These veins mostly commonly connect
with the abdominalepelvic venous network and reflux may
be elicited during Valsalva or calf release. They may or may
not connect with the main trunk of the GSV or AASV. DUS
imaging may reveal reflux in one or more of these visible
veins.28
Details of Treatment or Procedure
Sufficient details of any treatment should be documented
to permit informed DUS follow-up. These are described as
minimum requirements in Table 2. Additional details can be
included, as required, to fulfil the requirements of specific
studies.
Timing of Post-treatment DUS Evaluation
There are several purposes for DUS follow-up. These
include assessment of adequacy of the initial treatment
and of complications, identifying possible need for further
intervention, identifying the evolution of deterioration and
recurrence, carrying out research into treatment mecha-
nisms and outcomes and, in due course, to identify surro-
gate end points of long-term outcomes. The intendedpurpose, as well as the cost and the feasibility of inviting
patients to re-attend, will influence the frequency of
repeated assessments.
Immediate: 1e4 weeks after treatment
This is indicated:
(1) For single ‘oneestop’ treatments, such as surgery or
endovenous thermal ablation, where it is desirable to
know whether the intervention has achieved the
intended immediate goal. Without this, it is impossible
to determine whether recurrence, should it occur, is
due to inadequate therapy (for instance, residual
incompetent GSV trunk after stripping). The presence
of post-treatment deep vein thrombosis should also be
assessed.29e33
(2) As part of sequential treatments, such as staged (foam)
sclerotherapy, combined procedures (phlebectomy þ
sclerotherapy), CHIVA (Cure Conservatrice et He´mody-
namique de l’Insuffisance Veineuse en Ambulatoire)
technique,34 etc.
Late follow-up
Formost patients, further DUS evaluationwill be required for
suspected recurrence. Repeat assessment is essential for
Duplex Reporting after Varicose Vein Treatment 93longer term prospective evaluation intended for the
purposes of research or clinical audit. For these purposes,
recommended follow-up is:
Short-term. Assessment should be performed 1 year
after the intervention to elicit ultrasound features that may
predict longer term outcome after treatment of GSV, AASV
or SSV. A vein obliterated at 1 year after endovenous
thermal ablation will usually remain so for at least 3e5
years in most cases.35,36 After surgery, 1-year assessment
detects newly developed incompetent veins (due to neo-
vascularisation or dilation of pre-existing veins) in the
treated areas.37e41 The finding of new incompetent veins in
the groin, which are larger than 4 mm in diameter, 1 year
after SFJ ligation results in a 100% probability of developing
a clinical groin recurrence and visible recurrent veins in the
thigh after 5 years.10
Mid-term. This should be considered after 2e3 years to
confirm the earlier changes; but, this interval after treat-
ment is still too short for conclusions on long-term
outcomes.6,41e43
Long-term. This should be performed at least 5 years
after treatment.6,36,44e47 This interval is long enough for
the development of clinical recurrence, which may have
arisen as a consequence of the incompetent veins detected
by the short- or midterm DUS scan.6,10,36
In addition to DUS imaging, clinical findings should be
evaluated using VCSS (or an alternative clinical score) and
QoL assessment at the same time intervals.12
If possible, a late DUS assessment can be performed
after 10 years or more.46,48e50 The longest reported DUS
follow-up after varicose vein surgery was done 34 years
after treatment, but, for obvious reasons, this was not
a prospective study.51 In practice, it is not easy to achieve
long-term follow-up in patients treated for varicose veins.DUS Imaging after Surgical or Endovenous
Treatment of Varicose Veins
Standardised preoperative DUS assessment and clinical
evaluation (see above) should combine a written report
with a diagrammatic representation of the data as an
adequate basis for further DUS comparisons.8A. DUS imaging after surgical treatment
Following surgical treatment, DUS imaging should focus on
the saphenous junctions (SFJ and SPJ) and keep track of the
stripped saphenous trunk (GSV, AASV or SSV). Sites of
previous perforator ligation should also be investigated.
Recurrent varices should be assessed as either:
(a) veins with reflux following a Valsalva or com-
pressionerelease manoeuvre, where a change of
compartment or escape point (connection with the
deep veins) exists; and
(b) veins where the reflux is not linked to an escape point
but is generated by the filling of the incompetent vein
by its tributaries. In these veins, a Valsalva manoeuvre
will not elicit reflux, whereas a compressionerelease
manoeuvre will show reflux in the relaxation phase.All ‘escape points’ should be documented, where
possible; in many cases of recurrent veins, no clear
communication with deep veins can be identified by DUS
examination.20,21,45
DUS of the SFJ
The SFJ is a common site of recurrence following
surgery.21,52 After classic SFJ disconnection (flush saphe-
nofemoral ligation and ligature-section of the related SFJ
tributaries), also called crossectomy or high ligation,
a number of features may be identified:
- Normal: This shows the common femoral vein (CFV)
without any residual segment of GSV or any incompe-
tent superficial vein in the groin, and the GSV terminal
valve is no longer visible.
- Neovascularisation or groin varicose network: Neo-
vascularisation is defined as new blood vessel forma-
tion (angiogenesis) occurring in abnormal tissue or in
an abnormal position, which is a histological diagnosis.
However, in the Vein-term consensus document, neo-
vascularisation has been accepted as a venous term,
defined as: “presence of multiple new, small tortuous
veins in anatomic proximity to a previous venous
intervention.”22 The consensus group has retained the
term ‘neovascularisation’ to describe the presence of
new veins situated at the site of the previous SFJ or SPJ
ligation (Fig. 1(a) and (b)).7,53e56 These veins may be
newly formed or can arise from dilation of existing
groin veins that were invisible on DUS before the
operation. They can be observed in the short-term,
mid-term or only at long-term follow-up.46 The
terms ‘neoreflux’, ‘angiodysplasia’ and ‘cavernoma’
should not be used anymore to avoid confusion with
other conditions.56e58 An alternative term for neo-
vascularisation at the SFJ could be ‘groin varicose
network’, which is a neutral descriptive term for the
newly visible veins, without suggesting any underlying
pathophysiology. If tortuous veins are seen in connec-
tion with a lymph node, they are properly described as
LNVN and these findings may or may not be part of the
neovascularisation pattern.58 Neovascular veins are
usually tortuous. They may exhibit reflux with a Val-
salva manoeuvre, and/or during release after calf
compression. Some neovascular veins have a normally
directed flow without reflux. With time, these veins
may establish a clear connection with superficial
tributaries or with an LNVN, or with a retained
saphenous trunk (which was not stripped intentionally
or unintentionally) or with other veins present in the
saphenous compartment after stripping, and become
larger. The largest diameter of the vein(s) of the
vascular network in the groin should be measured and
the veins should be checked for presence or absence of
reflux during calf compressionerelease and/or Valsalva
manoeuvre. If these veins exhibit reflux with a Valsalva
manoeuvre, the escape point usually lies in the SFJ
area. In some cases, there is a connection with
incompetent pelvic veins. If venous reflux is detected
in neovascular veins only during the calf release phase
(and not during Valsalva manoeuvre), this suggests that
they fill from the subcutaneous abdominal venous
Figure 2 Network of large refluxing veins originating from
the common femoral vein (CFV) through a residual GSV stump
with the incompetent terminal valve still visible (arrow).
Figure 1 (a) Network of tiny refluxing veins originating from
the common femoral vein (CFV) in the high ligation area sug-
gesting angiogenesis (neovascularisation). (b) Network of large
refluxing veins originating from the common femoral vein in the
high ligation areawithout residual stump neither terminal valve.
Figure 3 Early postoperative scan after GSV stripping
showing haematoma still visible in the strip track (arrows)
containing a network of multiple tiny refluxing veins.
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a direct communication (escape point) with the deep
veins.
- Residual stump: If GSV ligation has been performed at
a distance from the CFV (low ligation) instead of flush
with the SFJ, a residual stump may be seen. The
terminal valve can usually be seen with one or more
residual SFJ tributaries. The most common pattern of
recurrent veins is venous reflux via the SFJ, although
this is commonly associated with reflux in residual
tributaries. Reflux from the residual stump can connect
with a residual AASVor other varices (Fig. 2).Where the
terminal valve is competent, the stump receives inflow
from its tributaries that drain normally into the SFJ.
This pattern of flow is usually seen after successful EVA,
but may also be found after selective stripping of
the GSV trunk without a flush ligation, preserving
the saphenofemoral confluence.59,60 In prospective
studies, the diameter of a residual stump should be
measured and reflux in the stump or any of its
connections should be assessed on DUS.DUS of the above-knee GSV and of the AASV
After stripping of the above-knee GSV, the saphenous
compartment should be examined, to see whether the GSV
really is absent. If the GSV trunk is still completely or
partially present within its ‘saphenous eye’, the diameter
and length of the residual GSV segment should be recorded,
and reflux assessed using a calf compressionerelease
manoeuvre.
In the case of CHIVA, the persistence of the GSV trunk
with retrograde flow is part of the treatment itself, which
aims to redirect the saphenous blood flow towards
competent re-entry perforators in the thigh or calf.50
In patients who have had surgical stripping, revascular-
isation of the strip-track has been observed, with the
presence of multiple convoluted channels in the track of
the previously stripped GSV.61 It would be better to
describe this only as ‘multiple venous channels in the
saphenous compartment’ (see the primary varicose
network described earlier).28 The DUS image is typical in
transverse as well as in longitudinal view (Fig. 3). Reflux can
Figure 4 (a) A popliteal fossa perforating vein can be rec-
ognised from its typical location in front of the lateral condyle
of the femur (arrows). (b) Colour duplex image shows reflux in
this tortuous vein.
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with clinically obvious recurrent varicose veins. Reflux may
persist in the varicose network after stripping the GSV, or
the varicose network may dilate and become incompetent
postoperatively.
As the AASV is often involved in recurrence after GSV
stripping, this vein should be examined along its course
(usually from mid-thigh to the groin), including diameter
measurement. In particular, connections with any possible
escape point(s) usually located more cranially should be
examined, for example, a residual stump, refluxing pelvic
veins, LNVN, perforators, etc.
Much less common is recurrence in the posterior acces-
sory saphenous vein (PASV) (sometimes in connection with
a Giacomini vein). Typically in multiparous women,
incompetent abdominalepelvic veins can connect directly
with residual GSV segments, or superficial tributaries in the
thigh after surgery, although these may have been present
before surgery.28
DUS of the below-knee GSV
The below-knee GSV is studied in its saphenous compart-
ment. Residual reflux may be present in part or all of the
saphenous trunk below the knee, and the diameter should
be measured. GSV reflux within the saphenous compart-
ment below the knee may re-enter the deep venous system
through a distal re-entry perforator, without a connection
to any superficial varicose veins.
DUS of the SPJ and SSV
After SSV surgery at the level of the SPJ, DUS findings are
comparable to those at the SFJ after GSV surgery. However,
it is important to have details about the preoperative
anatomical and haemodynamic situation, as well as the
procedure performed, as this will assist interpretation of
the findings at the SPJ. Variations in SPJ anatomy are
common and haemodynamics of the popliteal fossa are
complex. The varying level of the SPJ in relation to the
popliteal skin crease, the potential presence of a thigh
extension of SSV or a Giacomini vein, the possible junction
of the SSV with one of the gastrocnemius veins before
joining the popliteal vein, the presence of a popliteal fossa
perforating vein and all the different haemodynamic situ-
ations related to these anatomical variations has been
described in detail in the two previous UIP Consensus
Documents on DUS investigation (including an illustrative
diagram).8,9
DUS imaging may highlight:
- normal postoperative findings. It is essential to specify,
if ligation has been performed flush at the level of the
popliteal vein, or at the confluence with one or more
gastrocnemius veins; in the latter case, a residual
stump has been left intentionally, since it represents
a common track between gastrocnemius vein(s) and the
proximal SSV.
- neovascularisation, or popliteal fossa varicose network
with, or without reflux. Comparable to the situation in
the groin, the neovascular veins may connect directly
to the popliteal vein, or they may connect with
incompetent veins in the posterior thigh (e.g., Giaco-
mini vein, thigh extension of the SSV, pelvic or glutealveins, sciatic nerve varices and sciatic veins). Typically,
reflux is most obvious during calf release (diastolic
phase). However, in a few cases, recurrent reflux within
the varicose network in the popliteal fossa and/or in
the residual stump may be elicited during calf
compression or contraction (systolic phase), with, or
without reflux during calf release. This specific hae-
modynamic pattern is exceptional and may indicate
impaired outflow in the popliteal and/or femoral vein
due to anatomical or functional abnormalities.8
- residual stump, with or without reflux. An incompetent
residual stump is frequently seen after SSV surgery. This
may arise from the great variation in level of the SPJ.9
Unfortunately, data concerning the outcome of SSV
surgery including mid- or long-term follow-up are
extremely scarce and very few studies have focussed on
the clinical recurrence rate and typical DUS
appearances.37,49,62e65
Recurrent varicose veins after SSV surgery may be
related to other kinds of anatomical and haemodynamic
patterns:9,66 (pre- or) postoperative incompetence of the
popliteal fossa perforating vein, which is a tortuous vein,
usually located laterally from the SPJ (Fig. 4(a) and (b)),
96 M. De Maeseneer et al.(pre- or) postoperative gastrocnemius vein incompetence
or (pre- or) postoperative popliteal vein incompetence.
Incompetent proximal veins (e.g., pelvic or gluteal veins,
sciatic nerve varices (Fig. 5) and sciatic veins) can connect
directly with residual SSV segments, and are frequently
seen in women with pelvic varicocoele.
DUS imaging of perforating veins
Perforating veins are described according to their location
above or below the knee, medial, anterior, lateral or
posterior as described in the UIP consensus document.9
Perforating vein incompetence is defined as a perforator
that allows outward flow of >0.5 s during calf relaxation or
release after distal compression.8,22 The fate of perforating
veins after surgical treatment has been studied extensively
in a large prospective study, which included DUS assess-
ment at 6 months, 1 year and 3 years.67 This study showed
that recurrent perforator incompetence after surgery is far
more common than previously recognised; correct adjust-
ment of DUS equipment is required to highlight low-velocity
reflux during calf relaxation or release, which may occur in
small perforators. In primary venous insufficiency, perfo-
rators that transmit part or the totality of the reflux from
the superficial into the deep venous system are described
as re-entry perforators.8,68 After saphenous stripping and
phlebectomy, they mainly show normal inward flow and
a diameter reduction at short- and mid-term follow-up,
though long-term data are still lacking.69,70
DUS imaging of tributaries and of non-saphenous veins
During DUS follow-up, the final report should include an
assessment of the main incompetent tributaries, theFigure 5 Sciatic nerve varices (posterior thigh view).intersaphenous veins and the non-saphenous veins (e.g.,
the lateral venous system).9 On the back of the thigh,
varicose veins may receive reflux from a gluteal plexus or
vulvar/perineal veins, and are often related to pelvic vein
incompetence. By carefully tracing these veins upwards
while eliciting reflux with a distal compressionerelease
manoeuvre, it is possible to detect the related pelvic vein
reflux. If clinically indicated, in selected patients, this may
be further evaluated by additional DUS or venographic
investigation of pelvic veins.B. DUS Imaging after Physical or Chemical EVA
(Laser, Radiofrequency or Foam Sclerotherapy)
EVA using laser energy, radiofrequency-generated thermal
energy or a chemical sclerosant (most frequently as foam)
has become increasingly popular for the treatment of
varicose veins. Wide varying criteria have been used to
classify the outcome after EVA.71 A joint statement ‘Rec-
ommended reporting standards for EVA for the treatment of
venous insufficiency’ has been published recently.12 DUS
efficacy criteria after foam sclerotherapy were discussed
during a European Consensus Meeting in Tegernsee,
Germany in 2006, and it was suggested these criteria could
be suitable for other EVAs too.13
To evaluate EVA of the GSV, SSV or AASV, DUS investi-
gation should focus on both the saphenous junctions (SFJ
and SPJ) and on the treated trunk. If additional surgery of
tributaries and/or of perforating veins has been performed,
DUS findings will be reported as mentioned above. DUS
imaging will describe the morphological and haemodynamic
situation at the same follow-up intervals as those for
evaluation of clinical outcome.
Thermal methods for EVA aim to obliterate the whole
vein length between the site of introduction of the fibre or
catheter and the incompetent junction. During radio-
frequency ablation (RFA), the catheter tip is usually posi-
tioned 1 cm distally from the ostium of the superficial
epigastric vein (2 cm from the SFJ).72e74 For endovenous
laser ablation (EVLA), the tip of the laser fibre is advanced
to within 0.5 and 3 cm from the SFJ.75e77 Similarly, for SSV
treatment, the catheter or fibre tip is positioned 1e2 cm
below the SPJ.78e80 In ultrasound-guided foam scle-
rotherapy (UGFS) or catheter-directed foam sclerotherapy,
an adequate volume of foam is delivered to obliterate the
target vein, usually in one or two sessions.13,43,81e83
DUS of the SFJ
After endovenous treatment of the GSV with laser, RFA or
foam, the terminal part of the GSV usually remains open
and permits drainage of one or more tributaries of the SFJ.
- Morphology: obliteration or patency? The presence of
a patent terminal portion of the GSV is considered to be
a normal finding after endovenous treatment, if it is
<3 cm in length. When only the distal incompetent part
of the GSV has been treated, the competent proximal
section will exceed 3 cm. The proximal section of the
GSV may receive inflow from a Giacomini vein,
pudendal veins and other tributaries.72 At the imme-
diate DUS scan (1e4 weeks after treatment), thrombus
Figure 6 (a) Thrombus extension into the CFV (arrows) after
thermal EVA (thrombus has developed in the GSV stump).
(b) Thrombus extension into the CFV after foam sclerothe-
rapyethrombus has developed along the anterior wall of the
GSV and CFV (arrows).
Duplex Reporting after Varicose Vein Treatment 97extension from the GSV into the CFV should be sought
(Fig. 6(a) and (b)). Protrusion of a thrombus into
the lumen of the CFV is very unusual (<1%) and
should always be considered a pathological
finding.11,30e33,84,85 The extent of the thrombus should
be assessed to assist in selecting appropriate treatment
and monitoring.86
- Haemodynamics: presence or absence of reflux.
Detection of low-velocity reflux requires proper
adjustment of Doppler and colour modules,8 and is of
great importance in assessment after EVA, where vein
compliance is usually reduced (because of diameter
reduction or disappearance); tiny vessels may show
reflux. To elicit venous reflux, a sufficiently high
compliance is necessary, while the energy/pressure
gradient is the second component.87 After EVA, DUS
usually shows a patent SFJ or SPJ with obliteration of
the upper GSV/AASV or SSV. This obliteration dramati-
cally reduces the compliance of the remaining few
centimetres of patent vein. As a result, there is aboli-
tion of the energy gradient needed to generate reflux
from the CFV through the SFJ, although valvularincompetence may still exist. Reflux will then not be
detectable during Valsalva and compressionerelease
manoeuvres in the proximal part of the GSV. The long-
term haemodynamic fate of the residual saphenous
stump after EVA is debated and its course should be
monitored during DUS follow-up. Persistence or reap-
pearance of reflux at the SFJ and/or at the level of the
saphenous stump is always considered pathological.
Any varicose veins in connection with this vessel should
be imaged; infrequently, this consists of an incompe-
tent non-obliterated saphenous trunk, but more often
recurrent thigh varicosities connect with the incompe-
tent part of the GSV in the groin, either through an
incompetent AASV or PASV, or directly. In some cases,
reflux can be provoked by a Valsalva manoeuvre or
after thigh compression (more easily than after calf
compression) in one or more tiny veins in the groin
lymph node area and this finding mimics neo-
vascularisation after saphenous stripping. Usually, no
connection with any visible varicose veins is detectable
at short-term follow-up. After EVA, the incidence of
this DUS pattern is very low (0e1%).88,89 The possible
future clinical significance of this finding is not clear yet
and the longest reported follow-up is limited to 5
years.36DUS of the above-knee GSV and of the AASV
Obliteration of the trunk can usually be observed on
completion of the procedure, but it usually takes 6e12
months before complete ultrasonographic disappearance is
achieved.72,89
- Morphology: obliteration or patency? Treated veins
(GSV and/or AASV) should be assessed by their
compressibility, as well as using colour flow. It is stan-
dard practice to treat the whole above-knee GSV with
EVLA and RFA and this vein should be obliterated in its
entire course. Foam sclerotherapy may be less tar-
geted, but, in most cases, a similar procedure and
outcome is expected. However, the sonographic
appearance of the obliterated vein will depend on the
stage of post-treatment evolution. In the initial stages,
the vein behaves differently depending on whether it
has been treated with EVLA, RFA or foam.90,91 Subse-
quent obliteration is characterised by progressive
reduction in vein diameter, often in an inhomogeneous
way over the length of the treated vein. In the final
stage of fibrotic transformation, the vein may disappear
completely on DUS imaging, or is transformed into
a fibrous cord that may be visible as a hyperechogenic
tract in the saphenous compartment. The time course
of this whole evolution varies between patients.89 The
outer diameter of the obliterated vein can be
measured, preferably on a transverse section, and the
residual inner lumen of the visible vein can be assessed
in case of partial or complete patency. Sometimes, an
obliterated vein can be seen with an inhomogeneous
content characterised by varying echogenicity, without
flow or reflux, but with a lumen that can be partially
compressed. The latter may be due to the presence of
blood or thrombus in the lumen in an early stage.
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The presence of reflux following a Valsalva or com-
pressionerelease manoeuvre is pathological. This
reflux may be present over the whole length of the
treated vein or may be segmental and the possible
escape points should be described (SFJ, perforating
vein, refluxing pelvic veins, etc.). Reflux distribution
in the saphenous trunk and/or tributaries, together
with the re-entry or refluxing perforators should be
noted. Whether the reflux is due to primary failure of
EVA treatment or re-canalisation after initial
successful obliteration (usually within 6 months) can
only be determined by performing serial DUS imaging.
Antegrade flow without reflux can sometimes be
demonstrated in a partially or completely patent
residual GSV trunk. This may result from reduced vein
size and the obliteration of re-entry points. No
conclusive data are available to help interpret the
significance of this finding, which might represent
a good pathophysiological result, as the reflux is
abolished.13 The most important morphological and
haemodynamic DUS findings after EVA of a saphenous
trunk are summarised in Table 3.
- Additional DUS evaluation above the knee. As the
AASV may be involved in recurrence after GSV abla-
tion, this vein should always be examined along its
course, and the presence or absence of reflux should
be assessed.76 Vice versa, after previous AASV abla-
tion, the GSV main trunk should be examined at
follow-up DUS. Although the PASV (and Giacomini
vein) can also play a role in recurrence, this is far less
frequent.DUS of the below-knee GSV
Although it is still a controversial issue,92 usually the GSV is
ablated just to the level of the knee, even if the below-
knee segment is also incompetent. Immediately after theTable 3 Main morphological and haemodynamic duplex
ultrasound findings after endovenous ablation of a saphe-
nous trunk.
Morphology:
(a) obliteration of the vein: total incompressibility and
absence of colour flow; the vein can be classified as
visible or nonvisible
(b) partial patency of the vein: partial compressibility
and presence of colour flow in a part of the lumen
(c) total patency of the vein: complete compressibility
and presence of colour flow in the totality of the
lumen
(d) outer diameter of the residual vein
(e) inner diameter of the residual lumen in case of partial
or total patency
(f) segmental obliteration/patency: length of the
obliterated, partially or completely patent segment(s)
Haemodynamics:
(a) absence of flow with both principal manoeuvres
(Valsalva, compression/release)
(b) antegrade flow during compression manoeuvre
(c) retrograde flow >0.5 s during one or both manoeuvresEVA procedure, the GSV below the knee may remain
competent or incompetent, or it may become incompetent
again later at DUS after an interval. Partial or complete
thrombosis of the below-knee GSV may occur after ablation
of the above-knee GSV.
DUS of the SPJ and SSV
Sonographic changes after endovenous treatment of the
SSV have been described less frequently than after GSV
treatment. Changes in the SPJ and SSV seem to be similar to
those of the SFJ and GSV, and should therefore be reported
in the same way. At the SPJ, proximal tributaries may
remain patent, particularly any extension of the SSV into
the thigh or the Giacomini vein. Taking into account the
variable level of termination of the SSV, the length of
patent SSV considered acceptable after treatment should
take the level of the SPJ as reference, rather than the skin
crease of the popliteal fossa. After EVA of the SSV, oblit-
eration of the treated SSV segment should be assessed and
the residual distal SSV segment should be tested for reflux.
DUS imaging of perforating veins
Incompetent perforating veins can be treated with laser or
radiofrequency using a technique-limiting thermal ablation
to a short vein segment, or with foam sclerotherapy. The
efficacy of all these treatments can be evaluated with DUS
imaging, illustrating the obliteration of the treated
perforating vein and abolition of outward flow during the
release (diastolic) phase of the compressionerelease
manoeuvre.8,93,94 Perforating veins that remain patent
should be reassessed to compare the normal inward flow
and pathological outward flow, with the aim of determining
the net flow. The latter is obtained by comparing mutually
pulsed Doppler curves of inward and outward flow during
distal compression and release.8,68 The course of the reflux
should be traced whenever it extends from the perforating
vein into any saphenous or tributary vein.
Standardisation of results after EVA in view
of scientific studies
The authors propose a classification (Table 4) allowing
precise analysis of the results after EVA, to enable
comparison of different techniques and to introduceTable 4 Proposed classification of duplex findings at the
junction (J) and at the treated trunk (T) after endovenous
ablation.
J: for SFJ or SPJ:
- J0: no patent stump
- J1, J2, J3, J4 etc.: junction with patent stump
of 1, 2, 3, 4 cm etc.
RD: reflux; R-: no reflux
T: for GSV/AASV/SSV trunk:
- Ti: invisible trunk
- To: obliterated trunk (diameter: .. mm)
- Tp: completely or partially patent trunk
(diameter: .. mm)
- To/Tp or Tp/To: segmental obliteration/patency or
patency/obliteration (length of patent segment: .
cm; diameter of residual lumen: . mm)
RD: reflux; R-: no reflux
Duplex Reporting after Varicose Vein Treatment 99a standard DUS assessment of outcome following any EVA
procedure. The situation at the level of the junction (J) and
the treated trunk (T) is recorded. Reflux is reported as
present (Rþ) or absent (Re). DUS findings at the level of the
SFJ or SPJ are described as J0, J1, J2, J3, J4, etc.,
according to the absence of any visible stump (J0) or the
presence of a stump with a patent length of, respectively,
1, 2, 3, 4 cm etc. If reflux is present, the site of connecting
refluxing tributaries should be specified. DUS findings at the
level of the treated saphenous trunk are reported as Ti
(invisible), To (obliterated) or Tp (patent) or a combination
of the latter in case of segmental obliteration. The pres-
ence or absence of reflux is reported as Rþ or Re. If reflux
is detected, the site of refluxing tributaries should be
described. Measurement of diameter and length of the
obliterated and/or patent segment of the saphenous trunk
are described using the same protocol. When the lumen of
the treated vein is partially obliterated in a segment of the
treated vein or in its total treated length, the diameter of
the residual lumen can be measured as well (Table 4).The Role of DUS Investigation in Clinical
Studies
Clinical outcome studies are designed to measure the
impact of therapy on clinically relevant variables, such as
patient satisfaction, quality of life and relief of symptoms.
They also examine clinical signs, such as the presence of
varicose veins, oedema and skin changes including venous
ulceration. DUS ultrasound assessment is used to comple-
ment the clinical evaluation, assessing the technical
success of treatment, which may determine the long-term
evolution of the treated leg. DUS is also ideal for quality
control of the initial intervention. Ideally, it is performed
by an independent observer. DUS data are objective and
reproducible, particularly when obtained and reported
using standard methodology, which facilitates reliable
collection of serial data in individual patients and in patient
groups.
Using a single grading system for clinical outcome that
combines symptom scores, clinical findings and DUS findings
to define the global outcome will result in an incoherent
system, as the relative importance of individual variables
may differ. It is therefore appropriate to report separately
on clinical outcome parameters and DUS findings in all
patients included in prospective studies, focussing on the
outcome of treatment of varicose veins, and the effect on
other grades of chronic venous disease.Acknowledgements
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